Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsAt CHEST 2026, Pettigrew reviewed STRATIFY and STORM-PE data, citing bleeding risk with low-dose alteplase and 90-day walk gains with thrombectomy.
At CHEST 2026, Jean Bourbeau, MD, said AI may support COPD diagnosis, remote monitoring, and posthospital care, though most tools still need validation.
Henrik Watz, MD, discusses 104-week OBERON, TITANIA, and PROSPERO data on tozorakimab in COPD presented at CHEST 2026.
Gabor Kovacs, MD, PhD, discusses phase 2a INSIGNIA PH-COPD results for inhaled frespaciguat presented at CHEST 2026.
Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD
TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD
TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD
1.
CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas
2.
Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.
3.
'It's rare and it's scary.' Dark spot on your fingernail could mean cancer
4.
Pain’s Toll: Frailty Risk for Childhood Cancer Survivors
5.
Study confirms link between breast density, higher breast cancer risk
1.
Ferroptosis-Modulating Therapies for Treatment-Resistant Malignancies
2.
Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals
3.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
4.
Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship
5.
Drug Exposure During Cytopenia: Clinical Considerations and Evidence-Based Management
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Coordinating Supportive Care During Cancer Treatment Delays
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge